Drugs / BI 135585
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01282970 | Feb → Jul 2011 | type 2 diabetes mellitus | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01286571 | Jan → Mar 2011 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01146886 | Jun → Sep 2010 | type 2 diabetes mellitus | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 135585 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01286571 ↗ |
| Route | Oral | “Part 1 - oral doses given to approximately 9 parallel groups of 8 subjects (6 on active and 2 on on placebo) on Day 1” NCT01146886 ↗ |